OriGene Technologies

OriGene Technologies, Inc. develops, manufactures, and sells genome wide research and diagnostic products for academic research, diagnostic, pharmaceutical, and biotech applications. The company offers cDNA clones, including TrueORF cDNA, viral ORF, destination vectors, TrueClones (human), TrueClones (mouse), organelle marker plasmids, MicroRNA tools, mutant and variant clones, plasmid purification kits, transfection reagents, and gene synthesis service; and shRNA, siRNA, reporter vectors, miRNA, qPCR reagents, transfection reagents, PolyA+ and total RNA products, first-strand cDNA synthesis, and CRISPR/Cas9 genome editing products. It also provides proteins and lysates, such as purified human proteins, over-expression cell lysates, mass spectrometry standard proteins, and protein purification reagents; UltraMAB IHC antibodies, IVD antibodies, TrueMAB primary antibodies, anti-tag and fluorescent proteins, loading controls, secondary antibodies, and controls and others; and anatomic pathology products, including human tissues, IHC antibodies, detection systems, and IHC accessories. In addition, the company offers luminex and ELISA kits, autoantibody profiling arrays, ELISA antibodies, luminex antibodies, assay development, fluorogenic cell assay kits, and assay reagents; human tissues, such as TissueFocus search tools, tissue RNA/DNA/protein lysate, tissue sections, tissue MicroArray, cancer protein lysate array, TissueScan cDNA array, and tissue blocks; and lab essentials. Further, it provides gene synthesis, genome editing, custom cloning, custom shRNA, custom protein/antibody, antibody specificity, and assay development services. The company solution in the research areas, including cancer biomarker research, RNAi, pathology IHC, stem cell research, ion channels, and protein kinase products. It sells its products through distributors worldwide, as well as online. OriGene Technologies, Inc. was incorporated in 1995 and is based in Rockville, Maryland.